10% discount using “MY10” code for order above $499 + Free Shipping
Price range: $35.00 through $100.00
Brand name – Omnacortil 5mg
Generic name – Prednisolone
Manufacturer – Macleods Pharmaceuticals Pvt Ltd
Packaging – 10 Tablets in 1 Strip
Delivery Time – 6 To 15 Days.
Omnacortil 5mg is a prescription oral tablet that contains Prednisolone as its active ingredient. Macleods Pharmaceuticals Ltd. manufactures this medicine. Macleods is one of India’s most respected and globally recognized pharmaceutical companies with a strong presence across multiple international markets. Prednisolone belongs to a class of drugs called corticosteroids. These are synthetic versions of the natural steroid hormones that the adrenal glands produce inside the body.
Omnacortil 5mg is the lowest commonly prescribed strength of Prednisolone. Doctors use it in three distinct ways. First, they prescribe it as a maintenance dose for patients with chronic conditions who need ongoing low-level corticosteroid support. Second, they use it as the final tapering step when reducing a patient from a higher dose. Third, they prescribe it for mild to moderate inflammatory conditions that do not require the stronger effect of higher doses. This versatility makes Omnacortil 5mg one of the most frequently dispensed corticosteroid strengths in clinical practice.
Doctors prescribe Omnacortil 5mg for a broad range of inflammatory and immune-related conditions. These include mild to moderate asthma, seasonal and chronic allergic conditions, rheumatoid arthritis maintenance, lupus management, inflammatory skin conditions such as eczema and psoriasis, inflammatory bowel disease maintenance, adrenal insufficiency replacement therapy, childhood nephrotic syndrome, and certain eye and ear inflammatory conditions. Additionally, doctors use it to maintain disease remission in patients who have already achieved initial control with a higher dose.
Macleods Pharmaceuticals produces Omnacortil 5mg in GMP-certified manufacturing facilities under strict international quality control standards. Because Macleods has a consistent and long-standing track record in pharmaceutical manufacturing, both doctors and patients rely on this medicine for dependable therapeutic results. Omnacortil 5mg is widely available across hospitals, clinics, and pharmacies. Its low dose, proven safety profile, and consistent quality make it one of the most trusted corticosteroid options for both short-term and long-term management.
To understand how Omnacortil 5mg works, it helps to first understand the role of cortisol. Cortisol is a natural hormone that the adrenal glands produce in response to stress, illness, and injury. It controls inflammation, regulates immune responses, and maintains overall body balance. When the body cannot produce enough cortisol, or when inflammation becomes more than the body can manage naturally, Prednisolone steps in to supplement this process artificially.
After a patient takes Omnacortil 5mg, Prednisolone enters the bloodstream and binds to glucocorticoid receptors inside cells throughout the body. This binding triggers a targeted series of biological changes. It reduces the production of pro-inflammatory chemicals such as prostaglandins, leukotrienes, and cytokines. These chemicals cause the redness, swelling, heat, and pain that characterize inflammatory conditions. At the 5mg dose, this anti-inflammatory effect is measured and controlled. It is strong enough to manage mild to moderate inflammation effectively without the more intense systemic suppression that higher doses produce.
For patients with chronic conditions such as rheumatoid arthritis, lupus, or inflammatory bowel disease, a small daily dose of Prednisolone helps keep the disease in a stable and controlled state. The 5mg dose provides just enough corticosteroid activity to prevent the condition from flaring while minimizing the side effects that come with prolonged high-dose therapy. This makes it the preferred maintenance strength for many patients on long-term corticosteroid treatment plans.
In patients with adrenal insufficiency, the adrenal glands cannot produce adequate amounts of cortisol on their own. Omnacortil 5mg replaces this missing cortisol. Because 5mg of Prednisolone corresponds roughly to the body’s natural daily cortisol output in terms of anti-inflammatory activity, this dose works particularly well as a physiological replacement therapy in adrenal insufficiency patients.
When doctors reduce a patient’s corticosteroid dose from higher strengths such as 20mg, 30mg, or 40mg, they do so gradually. The 5mg tablet plays a critical role in this tapering process. It allows doctors to make small, precise dose reductions as the patient approaches the end of their treatment course. This fine control reduces the risk of adrenal insufficiency during the final stages of tapering.
The dose of Omnacortil 5mg varies depending on the condition being treated and the stage of treatment. For maintenance therapy in chronic conditions, doctors commonly prescribe 5mg to 10mg once daily. For adrenal insufficiency replacement, 5mg once daily in the morning is a typical approach. For mild inflammatory conditions, doctors may start at 5mg and adjust based on clinical response. Because Omnacortil 5mg is also used as a tapering dose, patients previously on higher strengths arrive at 5mg as one of the final steps before stopping the medicine altogether.
Always take Omnacortil 5mg with food or milk. Taking it with a meal significantly reduces the risk of stomach irritation and gastrointestinal discomfort. Swallow the tablet whole with a full glass of water. Morning dosing after breakfast is strongly preferred. This timing aligns with the body’s natural cortisol rhythm, which peaks in the early morning hours. Morning dosing also reduces the likelihood of sleep disturbance, which some patients experience when taking corticosteroids later in the day.
For some patients on long-term maintenance therapy, doctors prescribe alternate-day dosing. This means taking a dose of Prednisolone every other day rather than every day. Alternate-day therapy reduces the cumulative corticosteroid load the body receives over time. As a result, it lowers the risk of long-term side effects such as adrenal suppression, weight gain, and bone thinning. Doctors use this strategy primarily for patients who need ongoing anti-inflammatory support but whose condition is stable enough to tolerate the reduced frequency.
Patients must never stop taking Omnacortil 5mg suddenly after a prolonged course, even at this low dose. Long-term use of even small amounts of Prednisolone can suppress the adrenal glands’ ability to produce natural cortisol. Stopping abruptly may trigger adrenal insufficiency. Doctors always plan a gradual reduction toward zero over several days or weeks, particularly for patients who have been on corticosteroid therapy for more than a few weeks.
Children require carefully calculated doses based on their body weight. Prednisolone dosing in children typically follows a milligram-per-kilogram formula. Because children are more sensitive to the effects of corticosteroids, doctors always aim to use the lowest effective dose for the shortest time possible. The 5mg tablet allows precise small-dose adjustments that suit younger and lighter patients. Parents must always follow the exact prescription the child’s doctor provides.
Patients with diabetes, high blood pressure, osteoporosis, peptic ulcer disease, or liver disease need careful monitoring during treatment, even at the 5mg dose. Always inform the doctor about all current medicines before starting Omnacortil 5mg. Several common medicines can interact with Prednisolone and either reduce its effectiveness or increase the risk of side effects. Never adjust the dose without the doctor’s direct approval.
Most patients tolerate Omnacortil 5mg well, particularly when compared to higher doses. At this lower strength, side effects tend to be milder and less frequent. Common side effects include mild increase in appetite, slight fluid retention, mood changes such as mild irritability or restlessness, mild stomach discomfort or indigestion, and occasional difficulty sleeping. These effects are generally manageable and often diminish as the body adjusts to the medicine.
Even at the low 5mg dose, long-term use can gradually produce more significant effects. These include progressive thinning of the skin, increased ease of bruising, slow wound healing, and gradual reduction in bone density that raises the risk of osteoporosis over time. Blood sugar levels may also rise modestly with sustained use, requiring closer monitoring in diabetic patients. Doctors address these risks by prescribing calcium, vitamin D, and stomach-protecting medicines alongside long-term Prednisolone therapy.
Some patients experience mild acne, slight skin flushing, mild headache, or a subtle increase in blood pressure during treatment. These effects appear less frequently at the 5mg dose and are usually manageable with simple lifestyle adjustments and regular monitoring. Patients should still report any new or persistent symptoms to their doctor for proper evaluation.
Although serious reactions are uncommon at this low dose, patients must seek immediate medical help if they experience any of the following:
Patients taking Prednisolone 5mg for more than three months need to pay particular attention to bone health. Even at this low dose, long-term corticosteroid use gradually reduces bone mineral density. Doctors typically recommend a diet rich in calcium, regular weight-bearing exercise, and supplementation with calcium and vitamin D. In some patients, doctors also assess bone density through a DEXA scan and may prescribe additional bone-protecting medicines such as bisphosphonates if the risk of fracture is elevated.
Omnacortil 5mg treats a wide range of mild to moderate inflammatory and immune-related conditions. These include asthma maintenance, allergic conditions, rheumatoid arthritis, lupus management, inflammatory bowel disease, eczema, psoriasis, and adrenal insufficiency. Doctors also use it as a long-term maintenance dose after achieving initial disease control with a higher Prednisolone strength.
Yes, 5mg is considered the lowest standard clinical dose of Prednisolone. Doctors classify doses below 7.5mg per day as low-dose corticosteroid therapy. At this level, the medicine provides meaningful anti-inflammatory support while keeping the risk of systemic side effects significantly lower than at higher doses. This makes Omnacortil 5mg suitable for long-term maintenance use in many patients.
For acute flares of mild to moderate inflammatory conditions, many patients notice improvement within one to two days of starting treatment. For chronic conditions where Omnacortil 5mg serves as a maintenance dose, the medicine works continuously in the background to keep inflammation suppressed and prevent disease flares. The speed of response also depends on the specific condition and whether the patient is starting fresh or continuing after a higher dose.
Yes, doctors sometimes prescribe Omnacortil 5mg for long-term use, particularly for patients with chronic autoimmune conditions, adrenal insufficiency, or conditions that require ongoing low-level corticosteroid support. However, even at this low dose, regular monitoring is essential. Doctors check bone density, blood sugar, blood pressure, and eye health periodically throughout any extended course of treatment.
No. Even at the low 5mg dose, stopping suddenly after prolonged use is not safe. Long-term use of Prednisolone, even at small doses, suppresses the adrenal glands’ cortisol production. Abrupt discontinuation can cause adrenal insufficiency. Doctors always create a gradual tapering plan, even when reducing from the 5mg dose to zero. Patients must follow this plan carefully and never stop the medicine without medical guidance.
Doctors use Omnacortil 5mg during pregnancy only when the potential benefit to the mother clearly outweighs the risk to the unborn baby. Some conditions, such as lupus and inflammatory bowel disease, actually require corticosteroid management during pregnancy to protect both the mother and baby. However, Prednisolone does cross the placenta, so the doctor carefully weighs all factors before recommending continued use. Pregnant women must always consult their doctor before starting or continuing this medicine.
Yes, Prednisolone suppresses immune activity. At the 5mg dose, this suppression is relatively mild compared to higher doses. However, patients on long-term low-dose therapy still have a modestly reduced immune response. They should avoid close contact with people who have active infections, chickenpox, or measles. Live vaccines must not be given during corticosteroid therapy. Patients must inform all healthcare providers that they are taking this medicine.
Mild weight gain is possible with Omnacortil 5mg, particularly during longer courses of treatment. Prednisolone increases appetite and can cause the body to retain some fluid. At the 5mg dose, however, this effect is much less pronounced than at higher strengths. Eating a balanced diet, reducing salt intake, and staying physically active all help minimize weight changes during treatment.
Elderly patients can generally use Omnacortil 5mg under medical supervision. However, elderly patients are more sensitive to the side effects of corticosteroids, particularly bone thinning, high blood pressure, blood sugar elevation, and increased infection risk. Doctors monitor elderly patients more closely and often prescribe protective supplements alongside treatment. The dose is always kept as low as possible for as short a time as the condition allows.
Patients with active systemic fungal infections or a known allergy to Prednisolone must not take this medicine. Those with active peptic ulcer disease, uncontrolled diabetes, severe osteoporosis, or active tuberculosis should use it only under extremely close medical supervision. Additionally, patients who have recently received a live vaccine must wait for the appropriate period before starting Prednisolone therapy.
Omnacortil 5mg serves more clinical purposes than any other Prednisolone strength. Doctors use it as a starting dose for mild conditions, a maintenance dose for chronic diseases, a tapering step when reducing from higher doses, and a replacement dose for adrenal insufficiency. This remarkable versatility means that patients across a wide range of diagnoses and treatment stages benefit from this single tablet strength.
For patients beginning corticosteroid treatment for the first time, the 5mg dose represents the gentlest and most cautious starting point. Because the dose is low, the body has more time to adjust and the risk of immediate side effects is minimized. At the same time, 5mg delivers genuine and clinically meaningful anti-inflammatory activity. Doctors therefore use it confidently when a condition requires corticosteroid support but does not demand an aggressive initial approach.
Many chronic inflammatory and autoimmune conditions require years of ongoing corticosteroid support to remain in remission. At 5mg, patients receive this necessary support while keeping long-term side effect risk at its lowest possible level within corticosteroid therapy. This balance between ongoing efficacy and minimized risk makes Omnacortil 5mg the most sustainable long-term corticosteroid option for most patients.
Tapering a patient off corticosteroids requires careful and precise dose reductions. Moving too quickly risks a disease flare or adrenal crisis. Moving too slowly exposes the patient to unnecessary side effects. Omnacortil 5mg gives doctors the fine level of dose control they need during the final stages of tapering. Because the tablet exists at this specific low strength, doctors can reduce the dose incrementally in a way that keeps the patient safe and comfortable throughout the process.
Patients with adrenal insufficiency depend on external corticosteroid replacement to function normally. Because 5mg of Prednisolone closely approximates the body’s natural daily cortisol output in terms of anti-inflammatory effect, Omnacortil 5mg works particularly well as a physiological replacement therapy. It restores the hormonal balance these patients lack without exposing them to unnecessarily supraphysiological doses.
The 5mg strength suits patients at both ends of the age spectrum. Children often require small, precisely measured doses that the 5mg tablet makes achievable. Elderly patients benefit from the lower systemic impact of this dose compared to higher strengths. Because the tablet is easy to swallow and allows flexible dosing adjustments, it adapts naturally to the needs of these more sensitive patient groups.
Macleods Pharmaceuticals operates across more than 100 countries and consistently ranks among India’s top pharmaceutical companies. Every Omnacortil 5mg tablet comes from a GMP-certified facility that meets the highest international manufacturing standards. Patients and their doctors can therefore trust completely that every tablet delivers a precise, consistent, and therapeutically effective dose of Prednisolone every time they use it.
Long-term corticosteroid treatment can become financially demanding when patients need it for months or years. Omnacortil 5mg, manufactured by Macleods Pharmaceuticals, delivers proven therapeutic quality at an accessible and affordable price point. This affordability ensures that patients who depend on ongoing low-dose Prednisolone therapy can access it consistently and without financial interruption throughout their entire treatment journey.
Disclaimer: This content serves informational purposes only and does not replace professional medical advice. Always consult a licensed healthcare professional before starting, stopping, or adjusting any prescribed medication.
Anti Allergic
Anti Allergic
Anti Allergic
Anti AllergicExplore Medicines
Select Using Category
